— Know what they know.
Not Investment Advice
Also trades as: GRVI (NASDAQ) · $vol 0M

UPXI NASDAQ

Upexi, Inc.
1W: +2.2% 1M: +5.7% 3M: -34.7% YTD: -53.9% 1Y: -85.6% 3Y: -98.0% 5Y: -99.0%
$0.88
+0.03 (+3.85%)
 
Weekly Expected Move ±13.9%
$1 $1 $1 $1 $1
NASDAQ · Consumer Defensive · Household & Personal Products · Alpha Radar Neutral · Power 48 · $64.7M mcap · 60M float · 4.02% daily turnover · Short 39% of daily vol
Smart Money Score
Watch 0
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$64.7M
52W Range0.54-9.115
Volume1,471,116
Avg Volume2,408,730
Beta-0.27
Dividend
Analyst Ratings
3 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOAllan Marshall
Employees59
SectorConsumer Defensive
IndustryHousehold & Personal Products
IPO Date2021-06-23
Websiteupexi.com
3030 North Rocky Point Drive Suite 420
Tampa, FL 33607
US
701 353 5425
About Upexi, Inc.

Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.

Recent Insider Trades

NameTypeSharesPriceDate
Dugan Lawrence A-Award 100,000 2026-07-03
Rudick Brian Benjami A-Award 400,000 2026-07-03
MARSHALL ALLAN A-Award 2,000,000 2026-07-03
Norstrud Andrew Jame A-Award 400,000 2026-07-03
Salkind Gene A-Award 100,000 2026-07-03

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms